Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Elizabeth R Hawkins, Reena R D’Souza, Astero Klampatsa Division of Cancer Therapeutics, The Institute of Cancer Research, London, UKCorrespondence: Astero KlampatsaThoracic Oncology Immunotherapy Group, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Su...
Enregistré dans:
Auteurs principaux: | Hawkins ER, D'Souza RR, Klampatsa A |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ebb64adc425b40b8aba3cb8d1d89150f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
par: Sergey Kulemzin, et autres
Publié: (2021) -
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
par: Christopher Sloas, et autres
Publié: (2021) -
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
par: Jessica Waibl Polania, et autres
Publié: (2021) -
Adoptive chimeric antigen receptor T cell (CAR-T) and Treg cell-based immunotherapies: Frontier therapeutic aspects in cancers
par: Mehran Bahraini, et autres
Publié: (2021) -
Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
par: Shalini K. Sureshbabu, et autres
Publié: (2021)